Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators
VIENNA, March 30, 2023 /PRNewswire/ — Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. Read More
External Communications & PR
Cromazeile 2, A-2100 Leobendorf, Austria
M.: +43 676 84 68 68 966
E: [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/croma-pharma-further-strengthening-its-portfolio-with-philart-biostimulators-301786087.html
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. AfternoonHeadlines.com takes no editorial responsibility for the same.